< Back to scientific publications

Magazine 9.06

Use of Plerixafor in Predicted and Proven Poor Mobilizer (according to GITMO criteria). Experience of Policlinico Universitario Tor Vergata”

Authors: Postorino M., Rossi R., Zizzari A. G., Marchesi F., Provenzano I., Franceschini L., Pupo L., Rizzo M., .Giannì L, Gumenyuk S., De Santis G., Renzi D., Guiducci G., Fiorelli E., Coniglione F., Puliti R., Berrini A., Dauri M..

Date: 2012

Scope of interest: Haematology




You may also be interested in:

Magazine 17,152

Diabetes Affects Antibody Response to SARS-CoV-2 Vaccination in Older Residents of Long-Term Care Facilities: Data From the GeroCovid VAX Study.

Authors: Virgilio E, Trevisan C, Abbatecola A, Malara A, Palmieri A, Fedele G, Stefanelli P, Leone P, Schiavoni I, Maggi S, Volpato S, Antonelli Incalzi R, Onder G; GeroCovid Vax Working Group; GeroCovid Vax Working Group.

Date: 2022

Scope of interest: diabetes


Read details
Report/Poster of Convention/Congress Act

High-grade gliomas: are epileptic seizures more sensitive than neuroimaging in predicting recurrence?

Authors: Martina Fanella, Mariarita Albini, Jinane Fattouch, Sara Casciato, Leonardo Lapenta, Alessandra Morano, Alessandro D’Elia, Maurizio Salvati, Alfredo Berardelli, Anna Teresa Giallonardo, Carlo Di Bonaventura

Date: 2013

Scope of interest: Epilepsy


Read details
Report/Poster of Convention/Congress Act

The Role of the Alzheimer’s Day Centre

Authors: Abatecola Angela Marie

Date: 2021

Scope of interest: Alzheimer's


Read details